Mexico and Korea will promote the free trade agreement between the two countries. Korean pharmaceutical companies show interest in the Mexican market

Foreign Minister Marcelo Ebrard Casaubon and his Korean counterpart Park Jin agreed to promote the Free Trade Agreement between the two nations, as well as the accession of the Asian country to the Pacific Alliance as an associated State.

The Korean foreign minister took advantage of the occasion to offer Mexico the donation of 800,000 doses of vaccines against Covid-19 for children, while stressing his agreement with Ebrard on the need to strengthen health cooperation between the two countries.

The head of the Ministry of Foreign Affairs heads a Mexican delegation, in which, in addition to officials from the Foreign Ministry, there are executives from the pharmaceutical and academic sectors, as well as Mexican businessmen.

During the tour, the different Mexican sectors will have work meetings with their Korean counterparts in which they seek to reach agreements on pharmaceutical, academic and innovation cooperation, as well as business deals.

As part of the activities of the Mexican delegation, the Undersecretary of Foreign Affairs, Carmen Moreno Toscano, held a working meeting with directors of the Korea Trade and Investment Promotion Agency (KOTRA), the Association of Pharmaceutical Entrepreneurs (KPTA) and South Korean companies interested in accessing the Mexican market.

On behalf of the Ministry of Foreign Affairs, the Mexican delegation is made up of the head of the Secretary’s Office, Daniel Millán; the general director of Political Planning and G20, Jennifer Feller; the general director for Asia-Pacific, Fernando González Saiffe; the general director of Cooperation Policy, Javier Dávila; the general director of Evaluation and Planning, Carlos Castillo, and the technical coordinator of the Office of the Secretary, Manola Zabalza.

From the pharmaceutical and academic sectors, the general director of the National Polytechnic Institute, Arturo Reyes Sandoval; the general director of the National Institute of Medical Sciences and Nutrition, Salvador Zubirán, David Kershenobich, and the general director of the National Institute of Genomic Medicine, Luis Herrera Montalvo.

Source: MEXICO INDUSTRY.